Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
The D2 dopamine receptor (DRD2) is one of the most well-established therapeutic targets for neuropsychiatric and endocrine disorders. Here, the authors report the crystal structure of the antipsychotic drug haloperidol bound to DRD2 via an extended binding pocket that distinguishes it from other D2-...
Guardado en:
Autores principales: | Luyu Fan, Liang Tan, Zhangcheng Chen, Jianzhong Qi, Fen Nie, Zhipu Luo, Jianjun Cheng, Sheng Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1936baecc46a4ba180565c58eeea1187 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intoxicación por Haloperidol (Haldol)
por: Filippa,Rolando, et al.
Publicado: (1976) -
Discovery of new molecular subtypes in oesophageal adenocarcinoma.
por: Daniela Berg, et al.
Publicado: (2011) -
Fluorescent ligands for dopamine D2/D3 receptors
por: Anni Allikalt, et al.
Publicado: (2020) -
Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats
por: Wesołowska A, et al.
Publicado: (2021) -
Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition
por: Carine Z. J. Lim, et al.
Publicado: (2019)